Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy in those with type 2 diabetes.

Semaglutide exposure was significantly associated with a higher incidence rate and independently predicted a higher risk for upcoming nonarteritic anterior ischemic optic neuropathy. HealthDay ...

Get Instant Summarized Text (Gist) Once-weekly semaglutide use in individuals with type 2 diabetes more than doubles the risk of developing nonarteritic anterior ischemic optic neuropathy (NAION ...

Findings seen for patients with type 2 diabetes during a 5-year period. (HealthDay News) — Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic ...

Following the onset of nonarteritic anterior ischemic optic neuropathy, regular stroke workup may be necessary.

Patients with vs without nonarteritic anterior ischemic optic neuropathy demonstrated an elevated risk for stroke. Individuals with vs without nonarteritic anterior ischemic optic neuropathy ...

including nonarteritic anterior ischemic optic neuropathy, neuromyelitis optica, inflammatory optic neuropathies (sarcoid, lupus and giant cell arteritis), infectious optic neuropathies (Lyme ...

We first highlighted this possible link back in July 2024, when researchers found that the class of drugs increased users' risk of developing non-arteritic anterior ischemic optic neuropathy ...